Bo Lak Total Liabilities

Latest as of June 2026: ₩8.77 Billion KRW ≈ $5.94 Million USD

Bo Lak total liabilities. Based on the latest financial reports, Bo Lak (002760) has total liabilities worth ₩8.77 Billion KRW (≈ $5.94 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 002760 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Bo Lak (2013–2025)

Total liabilities of Bo Lak from 2013 to 2025. This chart illustrates how Bo Lak's total liabilities have evolved over time, based on quarterly financial data. Explore 002760 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Bo Lak Competitors by Total Liabilities

The table below lists competitors of Bo Lak ranked by their total liabilities.

Company Country Total Liabilities
IHQ Inc
KO:003560
Korea ₩40.85 Billion
Electra Battery Materials Corp
V:ELBM
Canada CA$100.05 Million
Elicio Therapeutics Inc.
NASDAQ:ELTX
USA $23.39 Million
Able View Global Inc. Class B Ordinary Shares
NASDAQ:ABLV
USA $26.78 Million
Cybertech Systems And Software Limited
NSE:CYBERTECH
India Rs-2.12 Billion
HAV GROUP ASA
F:6HH
Germany €568.81 Million
IRIS Corporation Bhd
KLSE:0010
Malaysia RM211.90 Million
Birlesim Muhendislik Isitma Sogutma Havalandirma Sanayi & Ticaret Sirketi AS
IS:BRLSM
Turkey TL3.74 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Bo Lak's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002760 asset base.

Liquidity & Leverage Metrics

Bo Lak Total Liabilities Ratios Explained

Bo Lak total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bo Lak's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bo Lak (2013–2025)

The table below shows the annual total liabilities of Bo Lak from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 ₩10.51 Billion
≈ $7.12 Million
-16.79%
2024-12-31 ₩12.63 Billion
≈ $8.56 Million
+38.06%
2023-12-31 ₩9.15 Billion
≈ $6.20 Million
-26.97%
2022-12-31 ₩12.53 Billion
≈ $8.49 Million
+16.28%
2021-12-31 ₩10.77 Billion
≈ $7.30 Million
+6.60%
2020-12-31 ₩10.11 Billion
≈ $6.85 Million
-13.39%
2019-12-31 ₩11.67 Billion
≈ $7.91 Million
+22.17%
2018-12-31 ₩9.55 Billion
≈ $6.47 Million
+10.95%
2017-12-31 ₩8.61 Billion
≈ $5.83 Million
-17.14%
2016-12-31 ₩10.39 Billion
≈ $7.04 Million
+9.15%
2015-12-31 ₩9.52 Billion
≈ $6.45 Million
-8.14%
2014-12-31 ₩10.36 Billion
≈ $7.02 Million
-0.71%
2013-12-31 ₩10.44 Billion
≈ $7.07 Million
--

About Bo Lak

KO:002760 Korea Specialty Chemicals
Market Cap
$39.94 Million
₩58.94 Billion KRW
Market Cap Rank
#22527 Global
#1458 in Korea
Share Price
₩984.00
Change (1 day)
+0.31%
52-Week Range
₩837.00 - ₩1323.00
All Time High
₩4129.14
About

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docet… Read more